Authors

• Franklin Pass
• Laura van ‘t Veer (ORCID: https://orcid.org/0000-0002-9838-8298)
• Lamorna Brown Swigart (ORCID: https://orcid.org/0000-0003-2076-5177)
• Douglas Yee (ORCID: https://orcid.org/0000-0002-3387-4009)
• Adrian Edwards (ORCID: https://orcid.org/0000-0001-7432-2828)
• Justin Lengfeld (ORCID: https://orcid.org/0000-0002-5191-000X)
• Laura J. Esserman (ORCID: https://orcid.org/0000-0001-9202-4568)
• Gillian L. Hirst (ORCID: https://orcid.org/0000-0002-4502-0035)
• S.P. Stoesz
• Mark Hensley
• Heather Beckwith (ORCID: https://orcid.org/0000-0003-3227-7525)

Institutions

• University of Minnesota (US)
• University of California, San Francisco (US)
• Henley College (GB)
• University of Minnesota Medical Center (US)
• Minnesota Oncology (US)
• University of San Francisco (US)
• Shell (Netherlands) (NL)

Publication Details

Journal

Frontiers in Oncology

Published

2025-07-24

DOI

https://doi.org/10.3389/fonc.2025.1605120

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• National Institutes of Health
• National Cancer Institute